Detalhe da pesquisa
1.
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
Am J Hematol
; 95(1): 48-56, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31637757
2.
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.
Biol Blood Marrow Transplant
; 19(9): 1340-7, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23769990
3.
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
Br J Haematol
; 143(3): 395-403, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18759762
4.
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.
Blood Adv
; 1(24): 2247-2256, 2017 Nov 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29296873
5.
Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustard.
Clin Pharmacol Ther
; 76(3): 270-80, 2004 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-15371987
6.
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.
Blood
; 101(5): 2043-8, 2003 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12406916